Phase-II Trial Of Bharat Biotech’s Covaxin To Begin In September
New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has been found to be safe, according to preliminary results of Phase-I clinical trials. Covaxin is developed by Hyderabad-based Bharat Biotech in ...
